参考文献:10.1016/s0014-5793(99)00724-3 摘要:Chiarugi A, Rapizzi E, Moroni F, Moroni F. The kynurenine metabolic pathway in the eye: studies on 3-hydroxykynurenine, a putative cataractogenic compound. FEBS Lett. 1999 Jun 18;453(1-2):197–200. doi: 10.1016/s0014-5793(99)00724-3. 参考文献:10.1097/00004647-199907000-00007 摘要:Cozzi A, Carpenedo R, Moroni F. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J Cereb Blood Flow Metab. 1999 Jul;19(7):771–7. doi: 10.1097/00004647-199907000-00007.